author-photo

K. Pappa

ViiV Healthcare

2

Papers

20

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Switching to DTG/3TC fixed-dose combination (FDC) Is non-inferior to continuing a TAF-based regimen in maintaining virologic suppression through 48 weeks (TANGO Study)

2020 Journal of Infection and Public Health
Show All
- Source
- Cite
- Save
Citations (9)
Durable Efficacy of Dolutegravir (DTG) Plus Lamivudine (3TC) in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI Studies

2020 Journal of Infection and Public Health
Show All
- Source
- Cite
- Save
Citations (11)